Not all IGHV3-21 chronic lymphocytic leukemias are equal: Prognostic considerations

Autor: Baliakas, P. Agathangelidis, A. Hadzidimitriou, A. Sutton, L.-A. Minga, E. Tsanousa, A. Scarfò, L. Davis, Z. Yan, X.-J. Shanafelt, T. Plevova, K. Sandberg, Y. Vojdeman, F.J. Boudjogra, M. Tzenou, T. Chatzouli, M. Chu, C.C. Veronese, S. Gardiner, A. Mansouri, L. Smedby, K.E. Pedersen, L.B. Moreno, D. Van Lom, K. Giudicelli, V. Francova, H.S. Nguyen-Khac, F. Panagiotidis, P. Juliusson, G. Angelis, L. Anagnostopoulos, A. Lefranc, M.-P. Facco, M. Trentin, L. Catherwood, M. Montillo, M. Geisler, C.H. Langerak, A.W. Pospisilova, S. Chiorazzi, N. Oscier, D. Jelinek, D.F. Darzentas, N. Belessi, C. Davi, F. Ghia, P. Rosenquist, R. Stamatopoulos, K.

An unresolved issue in chronic lymphocytic leukemia (CLL) is whether IGHV3-21 gene usage, in general, or the expression of stereotyped B-cell receptor immunoglobulin defining subset #2 (IGHV3-21/IGLV3-21), in particular, determines outcome for IGHV3-

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2127::a44e004cd679f6ff393876043292d536
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3001712

Clinical effect of stereotyped B-cell receptor immunoglobulins in chronic lymphocytic leukaemia: A retrospective multicentre study

Autor: Baliakas, P. Hadzidimitriou, A. Sutton, L.-A. Minga, E. Agathangelidis, A. Nichelatti, M. Tsanousa, A. Scarfò, L. Davis, Z. Yan, X.-J. Shanafelt, T. Plevova, K. Sandberg, Y. Vojdeman, F.J. Boudjogra, M. Tzenou, T. Chatzouli, M. Chu, C.C. Veronese, S. Gardiner, A. Mansouri, L. Smedby, K.E. Pedersen, L.B. van Lom, K. Giudicelli, V. Francova, H.S. Nguyen-Khac, F. Panagiotidis, P. Juliusson, G. Angelis, L. Anagnostopoulos, A. Lefranc, M.-P. Facco, M. Trentin, L. Catherwood, M. Montillo, M. Geisler, C.H. Langerak, A.W. Pospisilova, S. Chiorazzi, N. Oscier, D. Jelinek, D.F. Darzentas, N. Belessi, C. Davi, F. Rosenquist, R. Ghia, P. Stamatopoulos, K.

Background: About 30% of cases of chronic lymphocytic leukaemia (CLL) carry quasi-identical B-cell receptorimmunoglobulins and can be assigned to distinct stereotyped subsets. Although preliminary evidence suggeststhat B-cell receptor immunoglobulin

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2127::4f86c704ad4083702b394f5773f24b17
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3127072

Detailed studies on the mechanism and factors mediating lipofection potency of cationic phosphonolipid-based gene transfer into human cells

Autor: Koumbi, D. Clement, J. C. Psarra, A. M. Sideratou, Z. and Yaouanc, J. J. Chatzouli, M. Samara, M. Loukopoulos, D. and Kollia, Panagoula

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2127::276b1c6bc9e748642dfafd2e5f41a785
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3138330

Chronic Lymphocytic Leukemia with Mutated IGHV4-34 Receptors: Shared and Distinct Immunogenetic Features and Clinical Outcomes.

Autor: Xochelli A; Institute of Applied Biosciences, CERTH, Thessaloniki, Greece.; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden., Baliakas P; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden., Kavakiotis I; Department of informatics, Aristotle University of Thessaloniki, Thessaloniki, Greece., Agathangelidis A; Institute of Applied Biosciences, CERTH, Thessaloniki, Greece.; Division of Experimental Oncology and Department of Onco-Hematology, IRCCS San Raffaele Scientific Institute, Milan, Italy., Sutton LA; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden., Minga E; Institute of Applied Biosciences, CERTH, Thessaloniki, Greece., Ntoufa S; Institute of Applied Biosciences, CERTH, Thessaloniki, Greece., Tausch E; Department of Internal Medicine III, Ulm University, Ulm, Germany., Yan XJ; Feinstein Institute for Medical Research, Northwell Health, Manhasset, New York., Shanafelt T; Department of Hematology, Department of Medicine, Mayo Clinic, Rochester, Minnesota., Plevova K; Central European Institute of Technology, Masaryk University, Brno, Czech Republic., Boudjogra M; Department of Hematology, Hopital Pitie-Salpetriere and University Pierre et Marie Curie, Paris, France., Rossi D; Division of Haematology, Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy., Davis Z; Department of Haematology, Royal Bournemouth Hospital, Bournemouth, United Kingdom., Navarro A; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic, University of Barcelona, Barcelona, Spain., Sandberg Y; Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands., Vojdeman FJ; Department of Hematology, Rigshospitalet, Copenhagen, Denmark., Scarfo L; Division of Experimental Oncology and Department of Onco-Hematology, IRCCS San Raffaele Scientific Institute, Milan, Italy., Stavroyianni N; Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece., Sudarikov A; National Research Center for Hematology, Moscow, Russia., Veronese S; Molecular Pathology Unit and Haematology Department, Niguarda Cancer Center, Niguarda Ca' Granda Hospital, Milan, Italy., Tzenou T; First Department of Propaedeutic Medicine, University of Athens, Athens, Greece., Karan-Djurasevic T; Institute of Molecular Genetics and Genetic Engineering, University of Belgrade, Belgrade, Serbia., Catherwood M; Department of Haemato-Oncology, Belfast City Hospital, Belfast, United Kingdom., Kienle D; Department of Internal Medicine III, Ulm University, Ulm, Germany., Chatzouli M; Hematology Department, Nikea General Hospital, Piraeus, Greece., Facco M; Department of Medicine, Hematology and Clinical Immunology Branch, Padua University School of Medicine, Padova, Italy., Bahlo J; Department I of Internal Medicine and Center of Integrated Oncology, University Hospital Cologne, Cologne, Germany., Pott C; Second Medical Department, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany., Pedersen LB; Department of Hematology, Rigshospitalet, Copenhagen, Denmark., Mansouri L; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden., Smedby KE; Department of Medicine Solna, Clinical Epidemiology Unit, Karolinska Institutet, Stockholm, Sweden., Chu CC; Feinstein Institute for Medical Research, Northwell Health, Manhasset, New York., Giudicelli V; IMGT®, the international ImMunoGeneTics information system®, Université de Montpellier, LIGM, Institut de Génétique Humaine IGH, UPR CNRS 1142, Montpellier, France., Lefranc MP; IMGT®, the international ImMunoGeneTics information system®, Université de Montpellier, LIGM, Institut de Génétique Humaine IGH, UPR CNRS 1142, Montpellier, France., Panagiotidis P; First Department of Propaedeutic Medicine, University of Athens, Athens, Greece., Juliusson G; Lund University and Hospital Department of Hematology, Lund Stem Cell Center, Lund, Sweden., Anagnostopoulos A; Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece., Vlahavas I; Department of informatics, Aristotle University of Thessaloniki, Thessaloniki, Greece., Antic D; Clinic for Hematology, Clinical Center, Belgrade, Serbia.; Medical faculty, University of Belgrade, Belgrade, Serbia., Trentin L; Department of Medicine, Hematology and Clinical Immunology Branch, Padua University School of Medicine, Padova, Italy., Montillo M; Molecular Pathology Unit and Haematology Department, Niguarda Cancer Center, Niguarda Ca' Granda Hospital, Milan, Italy., Niemann C; Department of Hematology, Rigshospitalet, Copenhagen, Denmark., Döhner H; Department of Internal Medicine III, Ulm University, Ulm, Germany., Langerak AW; Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands., Pospisilova S; Central European Institute of Technology, Masaryk University, Brno, Czech Republic., Hallek M; Department I of Internal Medicine and Center of Integrated Oncology, University Hospital Cologne, Cologne, Germany., Campo E; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic, University of Barcelona, Barcelona, Spain., Chiorazzi N; Feinstein Institute for Medical Research, Northwell Health, Manhasset, New York., Maglaveras N; Laboratory of Medical Informatics, Aristotle University of Thessaloniki, Thessaloniki, Greece., Oscier D; Department of Haematology, Royal Bournemouth Hospital, Bournemouth, United Kingdom., Gaidano G; Division of Haematology, Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy., Jelinek DF; Department of Immunology, Mayo Clinic, Rochester, Minnesota, United States., Stilgenbauer S; Department of Internal Medicine III, Ulm University, Ulm, Germany., Chouvarda I; Laboratory of Medical Informatics, Aristotle University of Thessaloniki, Thessaloniki, Greece., Darzentas N; Central European Institute of Technology, Masaryk University, Brno, Czech Republic., Belessi C; Hematology Department, Nikea General Hospital, Piraeus, Greece., Davi F; Department of Hematology, Hopital Pitie-Salpetriere and University Pierre et Marie Curie, Paris, France., Hadzidimitriou A; Institute of Applied Biosciences, CERTH, Thessaloniki, Greece. anastasiaxtz@gmail.com.; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden., Rosenquist R; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden., Ghia P; Division of Experimental Oncology and Department of Onco-Hematology, IRCCS San Raffaele Scientific Institute, Milan, Italy.; Università Vita-Salute San Raffaele and IRCCS Istituto Scientifico San Raffaele, Milan, Italy., Stamatopoulos K; Institute of Applied Biosciences, CERTH, Thessaloniki, Greece.; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.; Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece.

Publikováno v: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2017 Sep 01; Vol. 23 (17), pp. 5292-5301. Date of Electronic Publication: 2017 May 23.

Heterogeneous functional effects of concomitant B cell receptor and TLR stimulation in chronic lymphocytic leukemia with mutated versus unmutated Ig genes.

Autor: Chatzouli M; School of Biology, University of Athens, Athens 10679, Greece;, Ntoufa S, Papakonstantinou N, Chartomatsidou E, Anagnostopoulos A, Kollia P, Ghia P, Muzio M, Stamatopoulos K, Belessi C

Publikováno v: Journal of immunology (Baltimore, Md. : 1950) [J Immunol] 2014 May 15; Vol. 192 (10), pp. 4518-24. Date of Electronic Publication: 2014 Apr 09.